Functional ion channels in pulmonary alveolar type I cells support a role for type I cells in lung ion transport
- Meshell D. Johnson*,†,
- Hui-Fang Bao‡,§,
- My N. Helms‡,§,
- Xi-Juan Chen‡,¶,
- Zac Tigue‖,
- Lucky Jain‡,§,¶,
- Leland G. Dobbs*,‖,**, and
- Douglas C. Eaton‡,§,¶
- Departments of *Medicine,
- **Pediatrics, and
- ‖Cardiovascular Research Institute, University of California, San Francisco, CA 94143; and Departments of
- ‡Physiology and
- ¶Pediatrics, and
- §Center for Cell and Molecular Signalling, Emory University School of Medicine, Atlanta, GA 30322
-
Communicated by John A. Clements, University of California, San Francisco, CA, February 2, 2006 (received for review June 3, 2005)
Abstract
Efficient gas exchange in the lungs depends on regulation of the amount of fluid in the thin (average 0.2 μm) liquid layer lining the alveolar epithelium. Fluid fluxes are regulated by ion transport across the alveolar epithelium, which is composed of alveolar type I (TI) and type II (TII) cells. The accepted paradigm has been that TII cells, which cover <5% of the internal surface area of the lung, transport Na+ and Cl− and that TI cells, which cover >95% of the surface area, provide a route for water absorption. Here we present data that TI cells contain functional epithelial Na+ channels (ENaC), pimozide-sensitive cation channels, K+ channels, and the cystic fibrosis transmembrane regulator. TII cells contain ENaC and cystic fibrosis transmembrane regulator, but few pimozide-sensitive cation channels. These findings lead to a revised paradigm of ion and water transport in the lung in which (i) Na+ and Cl− transport occurs across the entire alveolar epithelium (TI and TII cells) rather than only across TII cells; and (ii) by virtue of their very large surface area, TI cells are responsible for the bulk of transepithelial Na+ transport in the lung.
Footnotes
- †To whom correspondence should be addressed. E-mail: meshell.johnson{at}ucsf.edu
-
Author contributions: M.D.J., L.J., L.G.D., and D.C.E. designed research; M.D.J., H.-F.B., M.N.H., X.-J.C., and Z.T. performed research; M.D.J., L.J., L.G.D., and D.C.E. analyzed data; and M.D.J., L.G.D., and D.C.E. wrote the paper.
-
Conflict of interest statement: No conflicts declared.
-
↵ †† Bourke, S., Helms, M. N., Kim, K. J., Crandall, E. D., Borok, Z. & Kemp, P. J. (2004) FASEB J. 18, A723 (abstr.).
- Abbreviations:
- TI,
- alveolar type I;
- TII,
- alveolar type 2;
- ENaC,
- epithelial Na+ channel;
- CTFR,
- cystic fibrosis transmembrane regulator;
- HSC,
- highly selective cation;
- NSC,
- nonselective cation;
- pS,
- picoSiemen;
- CNG,
- cyclic nucleotide-gated;
- Q-PCR,
- quantitative PCR.
- © 2006 by The National Academy of Sciences of the USA





